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 Age, sex, and the association between skin test responses and IgE titres with asthma 
Mohammad H.R, Belgrave D, Kopec Harding K, Murray C.S, Simpson A, Custovic A. 
Pediatr Allergy Immunol 
ABSTRACT 
Background: Skin prick tests (SPTs) and allergen-specific serum IgE (sIgE) measurements are the 
main diagnostic tools for confirming atopic sensitization. Results are usually reported as ”positive” or 
“negative”, using the same arbitrary cut-offs (SPT>3mm, sIgE>0.35 kUA/L) across different ages and 
sexes. We investigated the influence of age and sex on the interpretation of allergy test in the context 
of childhood asthma.  
Methods: In a population-based birth cohort (n=1051), we ascertained the information on 
asthma/wheeze (validated questionnaires), and performed SPTs and sIgE measurement to inhalant 
allergens (dust mite, cat, dog) at follow-ups between ages three and 11 years. We investigated the 
association between quantitative sensitisation (sum of SPT mean wheal diameters [MWD] and sIgE 
titres to the three allergens) and current wheeze and asthma across ages and sexes.  
 
Results: We observed a significant association between the SPT MWD and sIgE titres and 
wheeze/asthma at most ages and for both sexes. However, the strength of this association was age and 
sex-dependent. For SPTs, the strength of the association between MWD and asthma increased with 
increasing age; we observed the opposite pattern for sIgE titre. For any given SPT MWD/sIgE titre, 
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boys were significantly more likely to express clinical symptoms, particularly in early life; this 
difference between males and females diminished with age, and was no longer significant by age 11 
years.  
Conclusions: Age and sex should be taken into account when interpreting the results of skin tests and 
sIgE measurement, and age- and sex-specific normative data are needed for these allergy tests.  
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INTRODUCTION 
Atopic sensitization has been identified as a risk factor for asthma in a series of epidemiological 
studies (1-4). Skin prick tests (SPTs) and measurements of serum allergen-specific IgE antibodies 
(sIgE) are the most commonly used diagnostic tools for confirming sensitization. Both of these 
allergy tests are usually reported as either positive or negative (1-4), with SPT mean wheal diameter 
(MWD) at least 3mm greater than the negative control and sIgE titre >0.35 kUA/L generally 
considered as indices of sensitization (5). However, these cut-offs are arbitrary, and different decision 
points are sometimes utilized.  
In relation to the presence or absence of allergic disease, using the results of SPTs and sIgE 
measurement as dichotomous outcomes has high negative predictive values, but relatively poorer 
positive predictive values (5, 6), and individuals classified as “sensitised” often do not express any 
symptoms of allergic disease (7). There is compelling evidence in food allergy that quantification of 
sensitization to food allergens (either as the size of skin test MWD or sIgE titre) predicts allergic 
reactions with much greater certainty than dichotomous cut-offs (8, 9). Similarly, we have previously 
shown in the context of respiratory allergy that the increasing titre of sIgEs to common inhalant 
allergens (mite, cat and dog) is strongly associated with childhood wheezing and diminished lung 
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function (10), with a similar association between sIgE titre to grass pollen and symptoms of rhinitis 
(11). Furthermore, the sum of sIgE titres to mite, cat and dog amongst wheezy children aged three 
years strongly predicted the risk of wheeze persistence into later childhood (10). Quantification of 
atopic sensitisation may also have a role in ascertaining asthma control, with emerging evidence that 
asthma severity and the risk of future exacerbations increase with increasing size of skin tests and 
sIgE titres (12). 
Total and specific IgE levels have been shown to change with age, sex, location/exposure and 
ethnicity (13-15). Total IgE tends to increase in childhood until the age of 9-10 years, after which the 
levels generally plateau (16). There is also evidence that males have higher total IgE compared to 
females (17). Similarly, the size of skin test reaction to both allergens and histamine changes with age 
(18, 19). Despite this evidence, current interpretation of these commonly used allergy tests in the 
context of respiratory allergy does not generally take into account either age or sex of the patient (20).  
We hypothesized that the relationship between atopic sensitization and asthma differs between boys 
and girls, and at different ages. To address our hypothesis, we investigated the effects of age and sex 
on the association between sensitisation as a quantitative trait (size of skin test wheal diameter and 
titre of sIgE) and childhood wheezing and asthma.  
 
METHODS 
Study population 
The Manchester Asthma and Allergy Study is a population-based birth cohort (21, 22). Subjects were 
recruited prenatally and followed prospectively. Local Research Ethics Committee approved the 
study; parents gave written informed consent.  
Data sources  
Children attended review clinics at ages three, five, eight and 11 years. Validated questionnaires were 
interviewer-administered to collect information on parentally-reported symptoms and treatments 
received. We assessed sensitization to Dermatophagoides pteronyssinus, cat and dog using skin prick 
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tests at all ages (Bayer, Elkhart, Ind, USA); we measured sIgE to these inhalant allergens at ages 
three, five and eight years (ImmunoCAPTM, Phadia, Uppsala, Sweden).  
Definition of variables 
Quantitative atopic sensitisation: SPT MWD for each individual allergen was determined by 
summing the largest wheal diameter and its perpendicular axis, then dividing by two. We used the 
sum of SPT MWDs to dust mite, cat and dog, and the sum of sIgE titres to these three allergens as 
markers of quantitative sensitisation. The choice of allergens was based on our previous data that such 
definition of quantitative sensitisation rendered the strongest association between aeroallergen 
sensitization with wheeze presence and persistence in our study population (10, 11).  
To take into account the increase in histamine reactivity that occurs through life (19), we also 
expressed SPT results as a ratio of MWD to allergens/MWD to histamine control (10 mg/ml) at each 
age. 
Current wheeze: Defined as a positive response to the question “Has your child had wheezing or 
whistling in the chest in the last 12 months?”  
Current asthma: Defined as the presence of any two of the following three features: 1) Current 
wheeze; 2) Current use of asthma medication; and 3) Physician-diagnosed asthma ever (23). 
Statistical analysis 
Logistic regression was used to investigate whether quantitative atopy (separate models using SPT 
MWD and sIgE as covariates) is associated with wheeze/asthma at each age. Estimates of the 
magnitude of the effect were quantified as odds ratios (ORs) with 95% confidence intervals (95% CI). 
We then investigated whether the association between quantitative atopic sensitisation and current 
wheeze/asthma was modified by sex by including a covariate for sex-by-sensitisation interaction for 
each age group. Predicted probability curves were constructed using results obtained from logistic 
regression.  
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Analysis was then extended to a discrete-time longitudinal model to investigate whether the 
magnitude of quantitative sensitisation is significantly associated with current wheeze/asthma. We 
investigated: (i) a main effects model where we assumed that the effect of quantitative sensitisation on 
current wheeze/asthma was independent of age; and (ii) whether the effect of quantitative 
sensitisation on current wheeze/asthma was significantly modified by age by including an interaction 
term for quantitative sensitisation and age in model (i).  
As asthma, eczema and rhinitis may coexist in the same individual children more commonly than 
expected by chance (24, 25), we carried out additional analyses to assess the above associations with 
asthma presenting with coexisting eczema and rhinitis.   
 
RESULTS 
Participant flow and demographics 
Participant flow is shown in Figure E1. Of the 1184 recruited participants, 133 were randomized to a 
primary prevention study and were excluded from this analysis. Of the 1051 eligible subjects (586 
males), 864 underwent SPTs at age three years (of those, 23.5% had current wheeze, 14.7% had 
asthma, 9% were sensitized), 858 at age five (23.1% wheeze, 22.8% asthma, 12.9% sensitized), 836 at 
age eight (18.3% wheeze, 17.9% asthma, 15% sensitized) and 715 at age 11 years (20.8% wheeze, 
20.7% asthma, 11.2% sensitized). Blood sample for sIgE measurements was provided by 178 children 
at age three years (21.9% wheeze, 9.6% asthma, 21.9% sensitized), 534 at age five (22.7% wheeze, 
20.5% asthma, 22.5% sensitized) and 511 at age eight (18.4% wheeze, 16.0% asthma, 30.3% 
sensitized). There were no significant differences in the outcomes and demographic characteristics 
between children included and excluded from the analyses (data available on request).  
The cross-sectional association between skin test MWDs and sIgE titres to each individual allergen 
(mite, cat and dog) at different ages and the probability of contemporaneous current wheeze in the 
whole population is shown in Table E1; the results amongst males and females separately are 
presented in Table E2.  
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Quantitative sensitisation and the risk of wheeze and asthma: The impact of age 
Current wheeze: Statistically significant differences in the relation between SPT MWD and current 
wheeze were found at different ages (Figure 1A), with the strength of the association increasing with 
increasing age. The relative odds ratios from discrete longitudinal analysis comparing the association 
between SPT MWD and sIgE titre and wheeze between different ages are shown in Table 1. There 
were significant differences in the strength of the association of SPT MWD and wheeze between ages 
three and eight and 11 years, and ages five and eight years, but not between ages three and five, and 
eight and 11 years (Figure 1A, Table 1). However, no significant differences were observed between 
age groups for the association between sIgE titre and current wheeze (Figure 1B).  
Current asthma: Similar to the findings for current wheeze, the strength of the association between 
SPT MWD and asthma increased with increasing age, with significant differences in the slope 
between different ages (Figure 2A, Table 2). Statistically significant differences in the strength of the 
association were also observed between sIgE titres and asthma at different age groups, but in contrast 
to the association for SPT MWDs, the strength of the association between sIgE and asthma decreased 
with increasing age (Table 2, Figure 2B). 
Quantitative sensitisation and the risk of wheeze and asthma: The impact of sex  
There was a significant association (p<0.01) between wheeze and asthma and the sum of SPT MWDs 
in both sexes and for all age groups (Table E3). The relation was also significant between the sIgE 
titres and both outcomes, except at age three years among girls (p=0.14). Figure 3 shows predicted 
probability curves illustrating the relation between quantitative atopic sensitisation and current asthma 
amongst males and females (the associations for wheeze were almost identical; Table E3). For a given 
SPT MWD, males were significantly more likely to have wheeze/asthma than females at ages three 
and five years (Figure 3A-B). This sex difference diminished with age, and was no longer significant 
by age 8 years (Figure 3C). Similarly, for a given sIgE titre, males were more likely to have clinical 
symptoms (Figure 3). However, this was statistically significant only at age five for wheeze (p=0.03). 
An interactive logistic regression test revealed no significant interaction between sex and SPT MWD 
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in relation to current wheeze/asthma in all age groups, except at the age 11 years (p=0.04), and no 
significant interaction between sex and sIgE titre.  
Analysis of the effect of age and sex on the association between quantitative sensitisation and asthma 
with coexisting eczema and rhinitis rendered similar results (Tables E4-5). Expressing SPT results as 
a ratio of MWD to allergens/MWD to histamine did not materially alter the results for any of the 
outcomes (Table E6-7).   
 
DISCUSSION 
Key findings 
In a population-based birth cohort, we observed a significant association between the SPT MWD and 
sIgE titres to common inhalant allergens and wheeze/asthma at different ages, and for both sexes. 
However, the strength of this association was both age and sex-dependent. For SPTs, the strength of 
the association between MWD and asthma increased with increasing age; we observed opposite 
pattern for sIgE titre. For any given SPT MWD or sIgE titre, boys were significantly more likely to 
express clinical symptoms, particularly in early life; this difference between males and females 
appeared to diminish with age. 
Limitations  
As is the case with most epidemiological studies, we relied on parental reporting of symptoms to 
define current wheezing and asthma, and we acknowledge that this may lead to overestimation of 
their true prevalence. Although the definition of current asthma which we used is more stringent than 
a simple report of wheezing or a physician-diagnosed asthma only, it is reliant on parental reporting. 
Although the follow up rate of participant in the cohort was high, we were unable to obtain data on all 
outcomes (including answers to all questions, skin tests and sIgE) for all children. This was 
particularly relevant for the assessment of sIgE at age three years, which was measured in a relatively 
small proportion of children whose parents agreed to venepuncture. It is likely that as a consequence 
of having lower number of study participants who provided blood sample for sIgE measurement at 
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this age, we observed a significant association between sIgE titres and wheezing at all ages, with the 
exception of three-year old girls. However, it is of note that in the analyses which we carried out, 
there was no difference between children included or excluded in demographic characteristics and 
primary outcome measures, suggesting that it is unlikely that this has influenced the main results.  
We have not measured sIgE at age 11 years; however, we present the sIgE data at three different ages 
(three, five and eight years), which allowed us to carry out longitudinal analyses. 
Our definition of quantitative sensitisation included SPT and sIgE responses to mite, cat and dog, 
which were then related to lower respiratory tract symptoms. We wish to emphasise that different 
allergens may be relevant in other geographical regions, and for different clinical outcomes. 
One strength of the study is a relatively large sample of children from the population-based birth 
cohort, suggesting that our results are broadly applicable to the general population. 
We acknowledge that recent developments in molecular or component-resolved diagnostics may 
facilitate better assessment of allergic diseases compared to skin prick or sIgE tests to extracts made 
from whole allergen sources (26-28). However, it is likely that standard SPTs and sIgE measurements 
are going to be widely used in large parts of the world for years to come. 
Meaning of the study  
There was a striking difference in the age-related association between SPT MWDs and sIgE titres 
with wheezing and asthma. For SPT MWDs, we found that the strength of the association with 
clinical symptoms increased as the age increased. However, the opposite pattern was observed for 
sIgE titres, with the strength of the association with disease decreasing with increasing age. This may 
be due to differences between the two tests, with SPTs assessing the sIgE bound to mast cells in skin, 
and serum sIgE detecting free sIgE. One possible reason for the decrease in the strength of the 
association between sIgE and clinical symptoms in the older age groups could be due to the changes 
in the total IgE. The ratio of sIgE to total IgE may be a better biomarker in relation to the symptoms 
of allergic disease compared to sIgE titre per se. If the total IgE titres increase at a faster rate that 
sIgE, this could decrease the ratio of total IgE/sIgE and hence reduce the probability of symptoms at a 
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given sIgE level. It has recently been reported that among sensitised children, allergen-specific IgG 
antibodies and sIgG/sIgE ratios may be associated with the size of skin test responses and the 
probability of clinical symptoms (29). Little is known about temporal changes in inhalant allergen-
specific IgG antibodies, or IgG/IgE ratios during childhood. One important message offered by our 
results is that sIgE and SPT should not be used interchangeably to determine atopic sensitisation, and 
that these two tests provide complementary, rather than identical information.   
Our results suggest that for a given value of SPT MWD and sIgE titre, boys are more likely than girls 
to exhibit wheezing and asthma at all ages (although the magnitude of this differences appeared to 
diminish with age). It is well known that sex influences asthma development in a time-dependent 
fashion, with higher prevalence and more severe symptoms in boys than girls. However, this pattern 
reverses during adolescence, with females having a greater incidence and severity of symptoms as 
they reach adulthood (30). Most published reports speculate that this is due to a numerous changes 
occurring during puberty, although no precise mechanistic explanation for this time-dependent switch 
has been established.  
In summary, our results suggest that in clinical practice both age and sex need to be taken into 
account when interpreting the results of allergy tests (skin tests and specific IgE measurement). We 
suggest that age- and sex-specific normative data for both skin tests and sIgE are needed to fully 
capitalize on the potential value of these tests in the context of lower respiratory symptoms during 
childhood. 
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LEGEND FOR FIGURES  
 
Figure 1. Fitted probability curves from longitudinal analysis of the effect of age on the 
relation between quantitative atopy and current wheeze. 
A) SPT MWD  
B) sIgE titre 
 
Figure 2. Fitted probability curves from longitudinal analysis of the effect of age on the relation 
between quantitative atopy and current asthma.  
A) SPT MWD  
B) sIgE titre   
Figure 3. Predicted probability curves illustrating the relation between quantitative atopy and current 
asthma amongst males and females.  
A-C) SPT MWD 
D-F) sIgE titre 
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TABLES  
 
Table 1. The relative odds ratios from discrete longitudinal analysis comparing the 
association between SPT MWD and sIgEs and current wheeze.  
Bold: significant changes in association   
 
Age group 
comparisons 
Relative odds 
ratios 
Lower 
confidence 
interval (LCL) 
Upper 
confidence 
interval (UCL) 
P – value 
SPT MWD (mite+cat+dog) 
3 and 5 1.03 0.96 1.11 0.43 
3 and 8 1.22 1.12 1.33 <0.001 
3 and 11 1.14 1.05 1.24 0.002 
5 and 8 1.21 1.12 1.30 <0.001 
8 and 11 1.05 0.98 1.13 0.14 
sIgE titre (mite+cat+dog) 
3 and 5 0.96 0.92 1.00 0.056 
3 and 8 0.97 0.93 1.01 0.18 
5 and 8 0.99 0.97 1.01 0.23 
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Table 2. The relative odds ratios from discrete longitudinal analysis for the association 
between quantitative sensitisation and asthma at different ages.  
Bold: Significant changes in association.   
 
Age group 
comparisons 
Relative odds 
ratios 
Lower 
confidence 
interval (LCL) 
Upper 
confidence 
interval (UCL) 
P – value 
SPT MWD (mite+cat+dog) 
3 and 5 1.04 0.96 1.12 0.34 
3 and 8 1.20 1.10 1.30 <0.001 
3 and 11 1.14 1.05 1.24 0.002 
5 and 8 1.17 1.09 1.26 <0.001 
8 and 11 1.06 0.99 1.13 0.10 
sIgE titre (mite+cat+dog) 
3 and 5 0.97 0.94 0.99 0.029 
3 and 8 0.97 0.94 0.99 0.029 
5 and 8 0.98 0.97 0.99 0.04 
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